Two Sigma Investments, LP Horizon Therapeutics Public LTD CO Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $8.84 Million - $10.3 Million	-89,300 Reduced 84.72%	16,100 $1.86 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $7.04 Million - $8.21 Million	73,100 Added 226.32%	105,400 $10.8 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.97 Million - $2.09 Million	18,400 Added 132.37%	32,300 $3.53 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $20.4 Million - $37.2 Million	-326,500 Reduced 95.92%	13,900 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $20.1 Million - $28.8 Million	340,400 New	340,400 $21.1 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $379,038 - $481,626	-4,386 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $145,967 - $177,586	1,481 Added 50.98%	4,386 $473,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $1.46 Million - $1.95 Million	-20,387 Reduced 87.53%	2,905 $267,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $28.4 Million - $35.8 Million	-423,991 Reduced 94.79%	23,292 $1.7 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $20.5 Million - $29.7 Million	371,596 Added 490.96%	447,283 $34.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $2.29 Million - $4.31 Million	75,687 New	75,687 $4.21 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $6.63 Million - $10.3 Million	-266,624 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $3.81 Million - $5.5 Million	-149,989 Reduced 36.0%	266,624 $9.65 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $9.62 Million - $11.7 Million	-418,050 Reduced 50.09%	416,613 $11.3 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $19 Million - $23.8 Million	834,663 New	834,663 $20.1 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account